Octreotide + Somatostatin Interaction
Unknowninteraction on record
Description
Drugs Metabolized by CYP 450 Enzymes Clinical Impact: Limited published data indicate that somatostatin analogs including MYCAPSSA may decrease the metabolic clearance of compounds known to be metabolized by cytochrome P450 enzymes, which may be due to the suppression of GH.
Source: FDA drug label - octreotide